← Open Payments lookup

MICHELLE MARTIN: Open Payments

NPI 1750017604 · FAIRMONT, WV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,162 in 64 payments from 12 companies in 2025. Trend: 2023 $1,470 · 2024 $1,872 · 2025 $1,162

Food & beverage: $1,162
CompanyPaymentsAmount
ABBVIE INC.25$427
Otsuka America Pharmaceutical, Inc.10$198
Neurocrine BioSciences, Inc.4$86
Teva Pharmaceuticals USA, Inc.4$76
Alkermes, Inc.4$74
Takeda Pharmaceuticals U.S.A., Inc.4$68
Janssen Pharmaceuticals, Inc4$66
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)4$64
Axsome Therapeutics, Inc.2$32
Otsuka Pharmaceutical Development & Commercialization, Inc.1$28

Products named: VRAYLAR, REXULTI, INGREZZA, AUSTEDO XR, ARISTADA, TRINTELLIX, CAPLYTA, SPRAVATO.

Industry payments across WV — which companies pay providers there.